16679-full
StrkL
Sex: M
Data Quality: 3 stars
Parkinson's: 10 yrs
Hoehn-Yahr 3 Type: Parkinson's disease Off
Mouth/throat: mild
Arms: none
Chest: none
Legs: moderate
StrkL
Male, 63 years
CO, United States
Primary Condition
Parkinson's and 2 more
Type
Parkinson's disease
First symptom
Diagnosis
Interests
Advocacy, and Research
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

StrkL's Comtan is for:

StrkL's side effects of Comtan:

StrkL's Comtan History (Ongoing)
Comtan (entacapone)
200 mg Daily Mar 20 - Apr 10, 2010
400 mg Daily Apr 10 - May 01, 2010
600 mg Daily May 01, 2010 - Last Update
Evaluations
Date Dosage Wearing off effect Perceived effectiveness Parkinson's Disease Perceived effectiveness Side Effects Adherence Burden
May 22, 2010 600 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4   MildMildMildMild AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
May 22, 2010
Advice & Tips
Since going to three doses a day, I frequently have no off time, from about half an hour after I take the medication first thing in the AM, until 8 or 9 at night. Sometimes I"m still on at 10 PM when I go to bed.
Cost
$25-49 monthly

About Comtan (Prescription Drug)

Comtan® is a brand name for the drug entacapone, a catechol-o-methyltransferase (COMT) inhibitor indicated as an adjunct treatment for patients taking levodopa and carbidopa for Parkinson’s Disease who experience the signs and symptoms of end-of-dose “wearing-off”.

Learn more about Comtan in our Comtan Community Report.

Back to StrkL's Profile